alogliptin/pioglitazone

CHEBI:CHEBI_747578

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20241231
dosage_form
TABLET, FILM COATED
active_ingredient_strength
45 mg/1
active_ingredient_name
ALOGLIPTIN BENZOATE
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
Takeda Pharmaceutical Co LTD
generic_name
alogliptin/pioglitazone
product_ndc
11532-7106
marketing_start_date
20120207
spl_id
521c5911-a78c-48b4-9b10-590a2a527023
package_ndc
11532-7106-1
package_description
65000 TABLET, FILM COATED in 1 DRUM (11532-7106-1)
package_marketing_start_date
07-FEB-12
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class